doi: 10.1161/hc4901.100524
(Circulation. 2001;104:2898.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Comparison of Use of Medications After Acute Myocardial Infarction in the Veterans Health Administration and Medicare
From the Houston Center for Quality of Care and Utilization Studies, a Health Services Research and Development Center of Excellence; Houston VA Medical Center; and Section for Health Services Research, Baylor College of Medicine, Houston, Tex (L.A.P.); the Department of Health Care Policy, Harvard Medical School (S-L.T.N., B.J.M.), and the Department of Biostatistics (S-L.T.N.) and Department of Health Policy and Management (L.L.L.), Harvard School of Public Health, Boston, Mass; and the Department of Radiology, Brigham and Women’s Hospital, Boston, Mass (B.J.M.).
Correspondence to Laura A. Petersen, MD, MPH, Health Services Research and Development (152), Houston Veterans Affairs Medical Center, 2002 Holcombe Blvd, Houston, TX 77030. E-mail laurap{at}bcm.tmc.edu
Background— There is concern that care provided in the Veterans Health Administration (VA) may be of poorer quality than non-VA health care. We compared use of medications after acute myocardial infarction in the VA with that in non-VA healthcare settings under fee-for-service (FFS) Medicare financing.
Methods and Results— We used clinical data from 2486 VA and 29 249 FFS men >65 years old discharged with a confirmed diagnosis of acute myocardial infarction from 81 VA hospitals and 1530 non-VA hospitals. We reported odds ratios (ORs) for use of thrombolytics, ß-blockers, ACE inhibitors, or aspirin among ideal candidates adjusted for age, sample design (hospital academic affiliation, availability of cardiac procedures, and volume), and within-hospital clustering. Ideal VA candidates were more likely to undergo thrombolytic therapy at arrival (OR [VA relative to Medicare] 1.40 [1.05, 1.74]) or to receive ACE inhibitors (OR 1.67 [1.12, 2.45]) or aspirin (OR 2.32 [1.81, 3.01]) at discharge and equally likely to receive ß-blockers (OR 1.09 [1.03, 1.40]) at discharge.
Conclusions— Ideal candidates in VA were at least as likely as those in FFS to receive medical therapies of known benefit for acute myocardial infarction.
Key Words: myocardial infarction • drugs • health care • thrombolysis
This article has been cited by other articles:
 |
|
 |
|
  L. A. Petersen, L. D. Woodard, L. M. Henderson, T. H. Urech, and K. Pietz Will Hypertension Performance Measures Used for Pay-for-Performance Programs Penalize Those Who Care for Medically Complex Patients? Circulation, June 16, 2009; 119(23): 2978 - 2985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Ross, S. Keyhani, P. S. Keenan, S. M. Bernheim, J. D. Penrod, K. S. Boockvar, A. D. Federman, H. M. Krumholz, and A. L. Siu Use of Recommended Ambulatory Care Services: Is the Veterans Affairs Quality Gap Narrowing? Arch Intern Med, May 12, 2008; 168(9): 950 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. U. Himmelstein, K. E. Lasser, D. McCormick, D. H. Bor, J. W. Boyd, and S. Woolhandler Lack of Health Coverage Among US Veterans From 1987 to 2004 Am J Public Health, December 1, 2007; 97(12): 2199 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Ibrahim The Veterans Health Administration: A Domestic Model for a National Health Care System? Am J Public Health, December 1, 2007; 97(12): 2124 - 2126. [Full Text] [PDF]
|
|
|
|
 |
|
 I. L. Katzan, N. V. Dawson, C. L. Thomas, M. E. Votruba, and R. D. Cebul The cost of pneumonia after acute stroke Neurology, May 29, 2007; 68(22): 1938 - 1943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Vaughan-Sarrazin, B. Wakefield, and G. E. Rosenthal Mortality of Department of Veterans Affairs Patients Admitted to Private Sector Hospitals for 5 Common Medical Conditions American Journal of Medical Quality, May 1, 2007; 22(3): 186 - 197. [Abstract] [PDF]
|
|
|
|
 |
|
 W. Shrank, J. Avorn, C. Rolon, and P. Shekelle Effect of Content and Format of Prescription Drug Labels on Readability, Understanding, and Medication Use: A Systematic Review Ann. Pharmacother., May 1, 2007; 41(5): 783 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-L. T. Normand, R. E. Wolf, J. Z. Ayanian, and B. J. McNeil Assessing the Accuracy of Hospital Clinical Performance Measures Med Decis Making, January 1, 2007; 27(1): 9 - 20. [Abstract] [PDF]
|
|
|
|
|
|
C. Maynard, E. Lowy, J. Rumsfeld, A. E. Sales, H. Sun, B. Kopjar, B. Fleming, R. L. Jesse, R. Rusch, and S. D. Fihn The prevalence and outcomes of in-hospital acute myocardial infarction in the department of veterans affairs health system. Arch Intern Med, July 10, 2006; 166(13): 1410 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Stukel, F. L. Lucas, and D. E. Wennberg Long-term Outcomes of Regional Variations in Intensity of Invasive vs Medical Management of Medicare Patients With Acute Myocardial Infarction JAMA, March 16, 2005; 293(11): 1329 - 1337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bansal, V. Gaddam, Y. W. Aude, J. Bissett, I. Fahdi, L. Garza, J. Joseph, B. Molavi, B. V. Pai, A. Sinha, et al. Trends in the Care of Patients With Acute Myocardial Infarction at a University-Affiliated Veterans Afffairs Medical Center Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2005; 10(1): 39 - 44. [Abstract] [PDF]
|
|
|
|
 |
|
 S. M. Asch, E. A. McGlynn, M. M. Hogan, R. A. Hayward, P. Shekelle, L. Rubenstein, J. Keesey, J. Adams, and E. A. Kerr Comparison of Quality of Care for Patients in the Veterans Health Administration and Patients in a National Sample Ann Intern Med, December 21, 2004; 141(12): 938 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Woodard, N. R. Kressin, and L. A. Petersen Is Lipid-Lowering Therapy Underused by African Americans at High Risk of Coronary Heart Disease Within the VA Health Care System? Am J Public Health, December 1, 2004; 94(12): 2112 - 2117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Kerr, R. B. Gerzoff, S. L. Krein, J. V. Selby, J. D. Piette, J. D. Curb, W. H. Herman, D. G. Marrero, K.M. V. Narayan, M. M. Safford, et al. Diabetes Care Quality in the Veterans Affairs Health Care System and Commercial Managed Care: The TRIAD Study Ann Intern Med, August 17, 2004; 141(4): 272 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Perschbacher, G. S. Reeder, S. J. Jacobsen, S. A. Weston, J. M. Killian, A. Slobodova, and V. L. Roger Evidence-Based Therapies for Myocardial Infarction: Secular Trends and Determinants of Practice in the Community Mayo Clin. Proc., August 1, 2004; 79(8): 983 - 991. [Abstract] [PDF]
|
|
|
|
|
|
H. Singh and J. Kalavar Quality of Care for Hypertension and Diabetes in Federal- Versus Commercial-Managed Care Organizations American Journal of Medical Quality, January 1, 2004; 19(1): 19 - 24. [Abstract] [PDF]
|
|
|
|
 |
|
 H. S. Loeb and L. A. Petersen Use of Angiography in the Veterans Affairs Health Care System and Medicare N. Engl. J. Med., September 11, 2003; 349(11): 1093 - 1093. [Full Text] [PDF]
|
|
|
|
|
|
B. E. Landon, S.-L. T. Normand, D. Blumenthal, and J. Daley Physician Clinical Performance Assessment: Prospects and Barriers JAMA, September 3, 2003; 290(9): 1183 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Petersen, S.-L. T. Normand, L. L. Leape, and B. J. McNeil Regionalization and the Underuse of Angiography in the Veterans Affairs Health Care System as Compared with a Fee-for-Service System N. Engl. J. Med., May 29, 2003; 348(22): 2209 - 2217. [Abstract] [Full Text] [PDF]
|
|